Comparison of High-Intensity Interval Training With Moderate-Intensity Continuous Training in Chronic Non-Specific Low Back Pain Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-48
SponsorDow University of Health Sciences

About this trial

The goal of this clinical trial is to compare the HIIT with MICT in chronic non-specific low back pain patients. The main questions it aims to answer are:

* The broad aim of the study is to compare HIIT with MICT in pain reduction in chronic non-specific low back pain patients. * The purpose of this research is to compare HIIT with MICT on disability and quality of life among chronic non-specific low back pain patients. * It also attempts to investigate the relationship between the baseline attributes and outcome variables.

Researcher will compare the HIIT to MICT to see the effects on CNSLBP

Participants will be:

* Allocated to HIIT or MICT group for 6 weeks. * Assessed pre and post intervention. * Continuously monitored during treatment sessions.

Eligibility criteria

Qualifiers

Referred patients of back pain persisting for > 12 weeks with no identifiable specific cause or underlying pathology from DUH OPD who meet the eligibility criteria.

Age group 20-48 with either gender.

NPRS score ranging between 3 and 5 (mild to moderate).

Modified ODI score is mild to moderate.

Disqualifiers

Any client with a specific cause of LBP (neurological problems, fractures, malignancy, infections, or rheumatic diseases such as RA or ankylosing spondylitis).

Any client with cardiopulmonary problems (recent myocardial infarction, uncontrolled hypertension, asthma, COPD).

Any client with musculoskeletal disorders [injuries limiting exercises, spine injuries, recent trauma (fracture), scoliosis by Forward Adam's test].

Any client with metabolic conditions (thyroid problems, uncontrolled diabetes).

Trial design

Treatments tested in this trial

  • Brisk walk and jog
  • Normal walk

Treatment groups

80 Participants
are divided into 2 treatment groups